These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20369732)

  • 21. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
    Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
    Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of C3b and C4b by the CR1-like site in murine CR1.
    Kalli KR; Fearon DT
    J Immunol; 1994 Mar; 152(6):2899-903. PubMed ID: 8144890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
    Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
    Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
    Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
    Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD; Fearon DT
    Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human C3b receptor (CR1).
    Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
    Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of CR1 Knops polymorphism in the pathophysiology of malaria: Indian scenario.
    Gandhi M; Singh A; Dev V; Adak T; Dashd AP; Joshi H
    J Vector Borne Dis; 2009 Dec; 46(4):288-94. PubMed ID: 19959855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and function of the human C3b receptor.
    Fearon DT
    Fed Proc; 1984 Jul; 43(10):2553-7. PubMed ID: 6234186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations.
    Feinberg BB; Jack RM; Mok SC; Anderson DJ
    Am J Reprod Immunol; 2005 Dec; 54(6):352-7. PubMed ID: 16305660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
    Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA
    J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor.
    Rao N; Ferguson DJ; Lee SF; Telen MJ
    J Immunol; 1991 May; 146(10):3502-7. PubMed ID: 1827486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.